Procaspase combination therapy for glioblastoma
The invention provides compositions and methods for the induction of cell death, for example, cancer cell death. Combinations of compounds and related methods of use are disclosed, including the use of compounds in therapy for the treatment of cancer and selective induction of apoptosis in cells. The disclosed drug combinations can have lower neurotoxicity effects than other compounds and combinations of compounds..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Europäisches Patentamt - (2023) vom: 19. Dez. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
HERGENROTHER PAUL J [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Sonstige Themen: |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-12-19, Last update posted on www.tib.eu: 2024-01-03, Last updated: 2024-01-12 |
|---|
| Patentnummer: |
US11844798 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA018887775 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA018887775 | ||
| 003 | DE-627 | ||
| 005 | 20240112063603.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240105s2023 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA018887775 | ||
| 035 | |a (EPA)US11844798 | ||
| 035 | |a (EPA)49117298 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a HERGENROTHER PAUL J |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Procaspase combination therapy for glioblastoma |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2023-12-19, Last update posted on www.tib.eu: 2024-01-03, Last updated: 2024-01-12 | ||
| 520 | |a The invention provides compositions and methods for the induction of cell death, for example, cancer cell death. Combinations of compounds and related methods of use are disclosed, including the use of compounds in therapy for the treatment of cancer and selective induction of apoptosis in cells. The disclosed drug combinations can have lower neurotoxicity effects than other compounds and combinations of compounds. | ||
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a che | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a BOTHAM RACHEL C |4 aut | |
| 700 | 0 | |a FAN TIMOTHY M |4 aut | |
| 700 | 0 | |a GILBERT MARK J |4 aut | |
| 700 | 0 | |a HANDLEY MICHAEL K |4 aut | |
| 700 | 0 | |a JOSHI AVADHUT |4 aut | |
| 700 | 0 | |a RIGGINS GREGORY J |4 aut | |
| 700 | 0 | |a TARASOW THEODORE M |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 19. Dez. |
| 773 | 1 | 8 | |g year:2023 |g day:19 |g month:12 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/49117298/publication/US11844798A1?q=US11844798 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 936 | u | w | |j 2023 |b 19 |c 12 |
| 951 | |a AR | ||
| 952 | |j 2023 |b 19 |c 12 | ||